Literature DB >> 3169214

Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone.

S Pedersen1, G Fuglsang.   

Abstract

Thirty one children with asthma were treated with inhaled beclomethasone and budesonide in a randomized cross-over study of 2 x 6 weeks' duration. The excretion of free cortisol in two 24 hour urine samples, collected at the end of each treatment period, was significantly higher (mean = 76.3 nmol per day) during budesonide treatment than during beclomethasone treatment (mean = 53.7 nmol per day) (p less than 0.01). The difference between the two drugs was more pronounced in the eight children who received 1,000 and 1,200 micrograms per day than in the 22 children who received 800 micrograms per day. Four children had cortisol excretion below the normal range when treated with beclomethasone. This was seen in one child during budesonide treatment. The age of the child did not influence the result. The long term clinical significance of these findings has yet to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169214

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  Inhaled corticosteroids: benefits and risks.

Authors:  D M Geddes
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

2.  Bone turnover during high dose inhaled corticosteroid treatment.

Authors:  N J Ali; S Capewell; M J Ward
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

3.  Adrenal function and high dose inhaled corticosteroids for asthma.

Authors:  P K Yiallouros; A D Milner; E Conway; J W Honour
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

4.  Systemic effects of inhaled corticosteroids.

Authors:  J P Monson
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

5.  Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes.

Authors:  B H Jennings; K E Andersson; S A Johansson
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.

Authors:  B Meibohm; G Hochhaus; H Möllmann; J Barth; M Wagner; M Krieg; R Stöckmann; H Derendorf
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

Review 7.  Inhaled corticosteroids in children. Is there a 'safe' dosage?

Authors:  A L Boner; G L Piacentini
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

8.  Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.

Authors:  P H Brown; S P Matusiewicz; C Shearing; L Tibi; A P Greening; G K Crompton
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

9.  Bloodspot cortisol in mild asthma: the effect of inhaled corticosteroids.

Authors:  I J Doull; S J Donovan; P J Wood; S T Holgate
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

10.  Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.

Authors:  N H Birkebaek; G Esberg; K Andersen; O Wolthers; C Hassager
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.